2m 2m 2m 2m 2m 2m 2m
Cytosorbents (CTSO)
NASDAQ
$0.51+$0.03 (+5.63%)
Price as of Jun 03, 2026 7:29 PM EDT- $30.8MMarket Cap
- -52.00%1-Year Change
- Medical DevicesIndustry
Cytosorbents (CTSO)
$0.51+$0.03 (+5.63%)
CTSO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.48 | ||
Change | +$0.01 (+2.59%) | ||
Open | $0.48 | ||
High | $0.49 | ||
Low | $0.45 | ||
Previous Close | $0.47 | ||
Volume | 30,849 | ||
30-Day Average Volume | 103,848 | ||
1-Week Change | 3.76% | ||
1-Month Change | -21.86% | ||
1-Year Change | -52.00% | ||
3-Year Change | -84.42% | ||
5-Year Change | -94.02% | ||
Fundamentals | |||
Shares Outstanding | 62.8M | ||
Total Assets | $40.6M | ||
Market Cap | $30.8M | ||
Enterprise Value | $43.0M | ||
Period: QTR TTM FY | |||
Revenue | $8.9M | ||
Net Income | -$5.1M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$4.3M | ||
EBITDA | -$4.2M | ||
Net Working Capital | $1.5M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 14 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 12/05/2014 | ||
Earnings & Revenue